Consolidated Statement Of Comprehensive Income

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7572452

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
JPY
JPY
JPY
302,995,000,000 JPY
302,995,000,000 JPY
302,995,000,000 JPY
JPY
214,733,000,000 JPY
214,733,000,000 JPY
JPY
214,733,000,000 JPY
JPY
Other comprehensive income
Items that will not be reclassified to profit or loss
Remeasurements of defined benefit plans
583,000,000 JPY
3,630,000,000 JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income
-291,000,000 JPY
-22,000,000 JPY
Total of items that will not be reclassified to profit or loss
292,000,000 JPY
3,608,000,000 JPY
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations
3,022,000,000 JPY
1,467,000,000 JPY
Effective portion of cash flow hedges
-292,000,000 JPY
-3,072,000,000 JPY
Total of items that may be reclassified to profit or loss
2,733,000,000 JPY
-1,593,000,000 JPY
Other comprehensive income
3,025,000,000 JPY
2,015,000,000 JPY
Comprehensive income
JPY
2,442,000,000 JPY
JPY
306,020,000,000 JPY
303,578,000,000 JPY
306,020,000,000 JPY
JPY
218,363,000,000 JPY
216,748,000,000 JPY
-1,615,000,000 JPY
216,748,000,000 JPY
JPY
Comprehensive income attributable to
Owners of parent
306,020,000,000 JPY
216,748,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.